Brightlobe is conducting an NHS study to validate a new tablet game to assess neurodevelopment in young children. The goal is to diagnose neurodiverse conditions like autism and ADHD more efficiently, making the assessment process easier for families.
The study is aimed at families with young children aged 3 to 8.
Each participating child will receive up to £20 in vouchers and parents will need to provide consent and complete a questionnaire. More information about the study can be found in the sign-up link.